Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs

被引：23
作者：
Zhang, Lingzi [1 ]
Zhan, Peng [1 ]
Chen, Xuwang [1 ]
Li, Zhenyu [1 ]
Xie, Zhoumeng [1 ]
Zhao, Tong [1 ]
Liu, Huiqing [3 ]
De Clercq, Erik [2 ]
Pannecouque, Christophe [2 ]
Balzarini, Jan [2 ]
Liu, Xinyong [1 ]
机构：
[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, Jinan 250012, Shandong, Peoples R China
[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[3] Shandong Univ, Inst Pharmacol, Sch Med, Jinan 250012, Shandong, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2014年 / 22卷 / 01期
基金：
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词：
HIV-1; AIDS; NNRTIs; Synthesis; Anti-HIV-1; activity; REVERSE-TRANSCRIPTASE INHIBITORS; COLORIMETRIC ASSAY; ANTAGONISTS; DISCOVERY; AIDS; DNA;
D O I：
10.1016/j.bmc.2013.10.033
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of novel N-arylmethyl substituted piperidine-linked aniline derivatives were designed, synthesized and evaluated for their anti-HIV activity in MT-4 cells. All the new compounds showed moderate to potent activities against wild-type (wt) HIV-1 with an EC50 range from 0.022 to 2.1 mu M. Among them, compound 5a6 (EC50 = 0.022 +/- 0.0091 mu M, SI > 10,770) was confirmed to be the most potent and selective inhibitor, which proved more potent than DDI and DLV in a cell-based assay against wt HIV-1, and more efficient than NVP in an RT (reverse transcriptase) assay. Besides, it is worth noting that compound 7a1 retained moderate inhibitory activity (EC50 = 4.8 +/- 0.95 mu M) against the HIV-1 double RT mutant strain (K103N/Y181C). The preliminary structure-activity relationship was discussed and rationalized by molecular simulation. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：633 / 642
页数：10
相关论文
共 39 条
  • [21] Design, synthesis, and biological evaluation of novel trifluoromethyl indoles as potent HIV-1 NNRTIs with an improved drug resistance profile
    Jiang, Hai-Xia
    Zhuang, Dao-Min
    Huang, Ying
    Cao, Xing-Xin
    Yao, Jian-Hua
    Li, Jing-Yun
    Wang, Jian-Yong
    Zhang, Chen
    Jiang, Biao
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, 12 (21) : 3446 - 3458
  • [22] 3D-QSAR, molecular docking, and molecular dynamics analysis of novel biphenyl-substituted pyridone derivatives as potent HIV-1 NNRTIs
    Jiang, Huifang
    Li, Yeji
    Wang, Zhonghua
    Li, Shaotong
    Wu, Tianle
    Xiong, Fei
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (24) : 13603 - 13618
  • [23] Design, synthesis, and biological evaluation of benzo[4,5]thieno[2,3-d ]pyrimidine derivatives as novel HIV-1 NNRTIs
    Meng, Bairu
    Zhuo, Zongji
    Yu, Han
    Tao, Sining
    Chen, Zixuan
    De Clercq, Erik
    Pannecouque, Christophe
    Kang, Dongwei
    Zhan, Peng
    Liu, Xinyong
    CHINESE CHEMICAL LETTERS, 2024, 35 (06)
  • [24] Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazine
    Jin, KaiJun
    Sang, YaLi
    De Clercq, Erik
    Pannecouque, Christophe
    Meng, Ge
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (22) : 3491 - 3495
  • [25] Structure-based design of novel 2,4,5-trisubstituted pyrimidine derivatives as potent HIV-1 NNRTIs by exploiting the tolerant regions in NNTRIs binding pocket
    Zhou, Zhenzhen
    Xie, Minghui
    Zhuo, Zongji
    Wang, Yalin
    Zhao, Fabao
    Tao, Sining
    Liang, Zhening
    De Clercq, Erik
    Pannecouque, Christophe
    Zhan, Peng
    Kang, Dongwei
    Liu, Xinyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 289
  • [26] Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
    Monforte, Anna-Maria
    Ferro, Stefania
    De Luca, Laura
    Lo Surdo, Giuseppa
    Morreale, Francesca
    Pannecouque, Christophe
    Balzarini, Jan
    Chimirri, Alba
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (04) : 1459 - 1467
  • [27] Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors
    Johnson, Ted W.
    Tanis, Steven P.
    Butler, Scott L.
    Dalvie, Deepak
    DeLisle, Dorothy M.
    Dress, Klaus R.
    Flahive, Erik J.
    Hu, Qiyue
    Kuehler, Jon E.
    Kuki, Atsuo
    Liu, Wen
    McClellan, Guy A.
    Peng, Qinghai
    Plewe, Michael B.
    Richardson, Paul F.
    Smith, Graham L.
    Solowiej, Jim
    Tran, Khanh T.
    Wang, Hai
    Yu, Xiaoming
    Zhang, Junhu
    Zhu, Huichun
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (09) : 3393 - 3417
  • [28] Discovery of Novel Amino Acids (Analogues)-Substituted Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis, and Biological Evaluation
    Zhuo, Zongji
    Wang, Zhao
    Jing, Lanlan
    Zhang, Tao
    Ge, Anchao
    Zhou, Zhenzhen
    Liu, Ying
    Li, Xin
    De Clercq, Erik
    Pannecouque, Christophe
    Zhan, Peng
    Liu, Xinyong
    Kang, Dongwei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [29] Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors
    Dong, Ming-xin
    Lu, Lu
    Li, Haitao
    Wang, Xiaohua
    Lu, Hong
    Jiang, Shibo
    Dai, Qiu-yun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) : 3284 - 3286
  • [30] Design, synthesis, in vitro and in silico studies of novel 4-oxoquinoline ribonucleoside derivatives as HIV-1 reverse transcriptase inhibitors
    Forezi, Luana da S. M.
    Ribeiro, Mariana M. J.
    Marttorelli, Andressa
    Abrantes, Juliana L.
    Rodrigues, Carlos R.
    Castro, Helena Carla
    Souza, Thiago Moreno L.
    Boechat, Fernanda C. S.
    de Souza, Alessandra M. T.
    de Souza, Maria Cecilia B., V
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 194
1234